Výsledky vyhledávání - "Poulakaki, N."

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Role of CXCL13 and CXCL9 in Early Breast Cancer

Autor: Razis, E. Kalogeras, K.T. Kotsantis, I. Koliou, G.-A. Manousou, K. Wirtz, R. Veltrup, E. Patsea, H. Poulakaki, N. Dionysopoulos, D. Pervana, S. Gogas, H. Koutras, A. Pentheroudakis, G. Christodoulou, C. Linardou, H. Pavlakis, K. Koletsa, T. Pectasides, D. Zagouri, F. Fountzilas, G.

Background: Chemokines, cytokines in the immune microenvironment of tumors, may be associated with patient outcome. We assessed the impact of CXCL13 and CXCL9 on disease-free (DFS) and overall survival (OS), in an attempt to retrospectively evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::42fbdf14691b7da24715ed04bddddd8f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077827

Zobrazit plný text záznamu

Ki-67 Expression as a Factor Predicting Recurrence of Ductal Carcinoma In Situ of the Breast: A Systematic Review and Meta-Analysis

Autor: Poulakaki, N. Makris, G.-M. Papanota, A.-M. Marineli, F. Marinelis, A. Battista, M.-J. Boehm, D. Psyrri, A. Sergentanis, T.N.

Ki-67 is a marker of proliferating cells; this meta-analysis of cohort studies highlights that higher Ki-67 expression predicts recurrence rates in breast ductal carcinoma in situ. The predictive role of Ki-67 expression seems independent of cut-off

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::23ce713d7c6db814d3c091ca668ad8d5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086578

Zobrazit plný text záznamu

Vulvar, Perianal and Perineal Cancer after Hidradenitis Suppurativa: A Systematic Review and Pooled Analysis

Autor: Makris, G.-M. Poulakaki, N. Papanota, A.-M. Kotsifa, E. Sergentanis, T.N. Psaltopoulou, T.

BACKGROUND Hidradenitis suppurativa (HS) is a chronic inflammatory disease that frequently involves the perineal and perianal regions. The association between HS and malignant transformation is a rare but under recognized phenomenon. OBJECTIVE This s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::b51bfe52c6f770216db7b1f0a9f22235
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126613

Zobrazit plný text záznamu

Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?

Autor: Poulakaki, N. Makris, G.-M. Battista, M.-J. Böhm, D. Petraki, K. Bafaloukos, D. Sergentanis, T.N. Siristatidis, C. Chrelias, C. Papantoniou, N.

Purpose: Local recurrence is considered a major concern in patients diagnosed with ductal carcinoma in situ (DCIS), as its invasive occurrence is associated with high rates of distant disease and mortality. This study aims to assess the possible corr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::7aea41ff5e920ddb872d14f2d0909e79
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086242

Zobrazit plný text záznamu

The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients

Autor: Koumarianou, A. Christodoulou, M.-I. Patapis, P. Papadopoulos, I. Liakata, E. Giagini, A. Stavropoulou, A. Poulakaki, N. Tountas, N. Xiros, N. Economopoulos, T. Pectasides, D. Tsitsilonis, O.E. Pappa, V.

Background: The host's immune system is crucially involved in cancer development and progression. The ratio of regulatory to effector T-cells, as well as the interplay of T-cells with therapeutic agents, impact on cancer prognosis. The current study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::48c868555de737651617d18b6eba68e5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3088357

Zobrazit plný text záznamu

Female sexuality after female cancer treatment: A clinical issue

Autor: Vaidakis, D. Panoskaltsis, T. Poulakaki, N. Kouloura, A. Kassanos, D. Papadimitriou, G. Salamalekis, E.

Purpose of investigation: The aim of the present study was to record how the treatment of female cancer may affect sexuality and interpersonal relations in the couple. Material and Methods: From September 2008 until February 2012, the authors prospec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::c58f5b05fb842769c98108634ec0dcc6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127056

Zobrazit plný text záznamu

Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO)

Autor: Gennatas, C. Michalaki, V. Carvounis, E. Psychogios, J. Poulakaki, N. Katsiamis, G. Voros, D. Kouloulias, V. Mouratidou, D. Tsavaris, N.

Aims and background: The understanding of hormonal therapies in postmenopausal women with metastatic breast cancer has advanced greatly in the past several decades. With the introduction of orally active, potent and selective third-generation aromata

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0fe61e86a8067d807268437d5c9567d3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3094920

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání